Brokers say these ASX 200 blue-chip shares are top buys in January

These blue chips have been given the thumbs up. Here's what analysts are saying about them.

| More on:
A man with a yellow background makes an annoncement, indicating share price changes on the ASX

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to add some ASX 200 blue chip shares to your portfolio in January, then the three listed below could be worth a look.

These ASX 200 shares have all been named as buys recently and tipped to rise meaningfully from current levels. Here's what you need to know about them:

Brambles Limited (ASX: BXB)

Macquarie thinks that Brambles could be an ASX 200 blue-chip share to buy. It is a supply chain solutions company that specialises in reusable pallets, crates, and containers for shared use.

The broker was pleased with the company's first-quarter performance and believes more of the same is coming. So much so, it suspects that Brambles could upgrade its FY 2024 sales growth guidance of 6% to 8% when it releases its half-year results next month.

Macquarie has an outperform rating and a $15.70 price target on Brambles shares.

Macquarie Group Ltd (ASX: MQG)

Another ASX 200 blue-chip share that could be a buy is Macquarie.

That's the view of analysts at Morgan Stanley, who believe that now could be the time to pounce on the investment bank's shares. Particularly given its belief that a return to form is coming in FY 2025, with the broker forecasting 20%+ earnings per share growth on normalising performance fees and gains on sale.

Morgan Stanley has an overweight rating and a $202 price target on its shares.

ResMed Inc. (ASX: RMD)

A final ASX 200 blue-chip share that has been named as buy is ResMed. It is a sleep treatment-focused medical device company with a portfolio of leading hardware and digital solutions.

Goldman Sachs is positive on the company and believes recent share price weakness has created a buying opportunity for investors. Its analysts "view [ResMed's] valuation as attractive and see a favourable risk-reward skew post the recent de-rate."

Goldman has a buy rating and a $32 price target on the company's shares.

Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Broker checking out the share price oh his smartphone and laptop.
Blue Chip Shares

2 ASX blue-chip shares offering big dividend yields

These businesses are predicted to pay significant passive income to shareholders.

Read more »

Smiling couple sitting on a couch with laptops fist pump each other.
Blue Chip Shares

2 dirt cheap ASX 200 blue chip shares to buy now with $10,000

Analysts think these cheap shares could be top buys.

Read more »

Young female investor smiling and speaking on mobile phone while sitting in front of laptop
Blue Chip Shares

Down 28% and 23%! Should I buy either of these 2 iconic ASX 200 shares?

These ASX blue-chips are trading at much cheaper prices. Are they buys to me?

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Blue Chip Shares

5 ASX 200 blue chip shares to buy in FY26 with $5,000

Analysts think these shares could be top picks for the new financial year.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Blue Chip Shares

2 ASX stocks to hold for steady gains

Analysts think these stocks could deliver the goods for investors.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Blue Chip Shares

The best ASX 200 blue chip shares to buy now with $3,000

Let's see why analysts think these are among the best stocks to buy right now.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Blue Chip Shares

Are these ASX 200 blue-chip shares undervalued?

Could now be time to jump in on these struggling blue chip holdings?

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Blue Chip Shares

The best blue chip ASX 200 shares to buy this month

Let's see which blue chips are best buys according to analysts at Bell Potter.

Read more »